©2014 Baishideng Publishing Group Inc.
World J Gastrointest Pharmacol Ther. Aug 6, 2014; 5(3): 148-155
Published online Aug 6, 2014. doi: 10.4292/wjgpt.v5.i3.148
Published online Aug 6, 2014. doi: 10.4292/wjgpt.v5.i3.148
Figure 1 Gastric motor abnormalities reported during critical illness.
CCK: Cholecystokinin; PYY: peptide YY.
Figure 2 Efficacy of metoclopramide (A), erythromycin (B) and combined erythromycin and metoclopramide (C) in the treatment of feed intolerance of critical illness over 7-d period.
Figure 3 Efficacy of rescue combined metoclopramide and erythromycin in critically ill patients who failed to response to either erythromycin or metoclopramide in the treatment of feed intolerance.
- Citation: Nguyen NQ. Pharmacological therapy of feed intolerance in the critically ills. World J Gastrointest Pharmacol Ther 2014; 5(3): 148-155
- URL: https://www.wjgnet.com/2150-5349/full/v5/i3/148.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v5.i3.148